AKT1 and hepatocellular carcinoma: Recent reports have shown that αvβ8 integrin expression is elevated in lenvatinib-resistant HCC cell lines Hep3B and Huh7 and the integrin confers lenvatinib resistance in HCC cells via the activation of the HSP90/AKT signaling pathway [48].